This page was printed from the Northern & Eastern Devon Formulary and Referral site at

Please ensure you are using the current version of this document

Community Access to Neutralising Monoclonal Antibodies (nMAB) and Oral Antivirals for Covid-19 Treatment

Last updated: 15-07-2022

Home > Referral > Key messages > Community Access to Neutralising Monoclonal Antibodies (nMAB) and Oral Antivirals for Covid-19 Treatment

First line
Second line
Specialist
Hospital

Learning
Urgent Care
Referral
Formulary

Website designed & developed by the CEMO Team, NEW Devon CCG, built by Reactor15

Key messages

Key messages

Referral feedback

Community Access to Neutralising Monoclonal Antibodies (nMAB) and Oral Antivirals for Covid-19 Treatment